Phase 1 Leiomyoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Lymphangioleiomyomatosis

National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT01799538

Recruiting

Phase 1

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

LymphangioleiomyomatosisLymphangioleiomyomatosis (LAM)

Columbia University20 enrolled2 locationsNCT06889168